Design and synthesis of oxadiazolidinediones as inhibitors of plasminogen activator inhibitor-1.
A novel series of PAI-1 inhibitors containing an oxadiazolidinedione moiety were identified by high through-put screening. Optimization of substituents by parallel synthesis and the iterative design toward understanding structure-activity relationship to improve potency are described.